February 18, 2026
TOPLINE: Bimekizumab produced better relief from plaque psoriasis symptoms and Dermatology Life Quality Index (DLQI) scores than secukinumab in a phase 3b study. METHODOLOGY: Researchers conducted […]
February 16, 2026
In a small case series, investigators used molecular diagnostic techniques to help identify an activating EGFR variant in patients with a novel acanthosis nigricans (AN) syndrome […]
February 16, 2026
TOPLINE: A study found that chronic graft-vs-host disease (cGVHD) has a similar or greater impact on skin-specific quality of life (ssQOL) compared to dermatomyositis (DM) and […]
February 13, 2026
TOPLINE: A population-based study of more than 2000 histologically confirmed cases found that the age-adjusted incidence of cutaneous T-cell lymphoma (CTCL) in the US among young […]
February 11, 2026
Steven R. Feldman, MD, PhD Medscape Dermatology asked Steven R. Feldman, MD, PhD, professor of dermatology at Wake Forest University School of Medicine, Winston-Salem, North Carolina, […]
February 11, 2026
It’s rare that terms such as “life changing,” “tremendous advance,” or “a difference of night and day” describe an evolving class of therapeutics without sounding like […]
February 11, 2026
TOPLINE: In a prospective pilot study of patients with cutaneous or systemic lupus erythematosus (LE), SIGLEC-1 expression correlated with disease activity and type I interferon (IFN-I) […]
July 8, 2025
Despite dramatic treatment advances in recent years, the dermatology community has lacked a unified definition for what remission means in plaque psoriasis. Now, a multistage Delphi […]
July 7, 2025
TOPLINE: In a US real-world analysis, only 51.5% of children with vitiligo received any treatment within 2 years of diagnosis, less often than adults. METHODOLOGY: Researchers […]